Diachrome
This article was originally published in The Tan Sheet
Executive Summary
CVS will be the first retailer to offer Nutrition 21's Diachrome nutrient-based insulin sensitizer for type 2 diabetes, the firm announces Feb. 22. "We believe Diachrome is a very promising product that addresses a healthcare crisis in the United States and worldwide and has significant market potential," Nutrition 21 COO Paul Intlekofer said, noting that the results of a 447-subject study on the safety and efficacy of Diachrome are to be published this summer. In addition, an economic analysis by Thomas Jefferson University shows that widespread use of Diachrome "could deliver significant health care savings" in the U.S. Efficacy and cost savings should encourage healthcare stakeholders to incorporate Diachrome into their treatment protocols." The move to CVS expands the firm's mass market presence: in January, Rite-Aid became the first retailer to carry the chromium picolinate supplement Chromax (1"The Tan Sheet" Jan. 23, 2006, In Brief)...